Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) saw a 34.7% decrease in short interest in December.
During December, there was a sizeable drop in the number of short positions held in Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS). As of December 30th, 571,700 …